Raiffeisen Bank International’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$998K Buy
14,266
+43
+0.3% +$2.87K 0.01% 416
2026
Q1
$880K Sell
14,223
-16,466
-54% -$1.15M 0.01% 399
2025
Q4
$2.06M Buy
30,689
+15,466
+102% +$1,000K 0.03% 254
2025
Q3
$1.01M Sell
15,223
-9,076
-37% -$718K 0.01% 337
2025
Q2
$2.06M Sell
24,299
-2,461
-9% -$193K 0.03% 217
2025
Q1
$1.81M Buy
26,760
+3,894
+17% +$318K 0.03% 223
2024
Q4
$1.78M Buy
+22,866
New +$1.69M 0.03% 223

Other funds holding DXCM

Raiffeisen Bank International's DXCM Position: Q2 2026 in Review

Raiffeisen Bank International increased its DexCom (DXCM) stake by 0.3% in Q2 2026, buying an estimated $2.87K and bringing the position to 14,266 shares worth $998K. The position accounts for 0.01% of the portfolio, ranked #416.

Raiffeisen Bank International first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.06M in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Raiffeisen Bank International held 14,266 shares of DexCom worth $998K as of Q2 2026.
  • Raiffeisen Bank International bought 43 DexCom shares in Q2 2026, an estimated $2.87K.
  • DexCom made up 0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #416 holding.
  • Raiffeisen Bank International first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's DexCom position peaked at $2.06M in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.